Stay updated on Pevonedistat Combination in AML Clinical Trial
Sign up to get notified when there's something new on the Pevonedistat Combination in AML Clinical Trial page.

Latest updates to the Pevonedistat Combination in AML Clinical Trial page
- Check5 days agoChange DetectedAdded a glossary and color-coded change explanations (green/red highlights) with updated revision labels (v3.4.0); these changes affect how history is displayed rather than the study data.SummaryDifference0.8%

- Check12 days agoChange DetectedA new revision entry v3.3.4 is added to the history, and the older revision v3.3.3 is removed.SummaryDifference0.1%

- Check41 days agoChange DetectedNew revision entry added: Revision: v3.3.3 is now listed in the study history. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 entry were removed from the page footer/history.SummaryDifference0.2%

- Check70 days agoChange DetectedThe page now shows Revision: v3.3.2 in the footer, and Revision: v3.2.0 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check77 days agoChange DetectedRemoved a site-wide government funding/operating status notice previously shown on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check98 days agoChange DetectedThe new screenshot shows updates to Study Status, Recruitment Status, IPDSharing, and other record sections across multiple history entries. These changes reflect the trial's progression and data-sharing status in the record.SummaryDifference0.1%

Stay in the know with updates to Pevonedistat Combination in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pevonedistat Combination in AML Clinical Trial page.